We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
+14.21%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$987M
AUM Growth
+$120M
(+14%)
Cap. Flow
+$63.5M
Cap. Flow
% of AUM
6.44%
Top 10 Holdings %
Top 10 Hldgs %
5.22%
Holding
1,870
New
579
Increased
363
Reduced
419
Closed
480
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$6.71M |
| 2 |
DexCom
DXCM
|
+$6.59M |
| 3 |
X
US Steel
X
|
+$6.1M |
| 4 |
CMBT
CMB.TECH NV
CMBT
|
+$5.09M |
| 5 |
SPLK
Splunk Inc
SPLK
|
+$4.85M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GOOS
Canada Goose Holdings
GOOS
|
+$21.9M |
| 2 |
Constellation Brands
STZ
|
+$9.52M |
| 3 |
Lumen
LUMN
|
+$7.13M |
| 4 |
Weyerhaeuser
WY
|
+$6.3M |
| 5 |
FedEx
FDX
|
+$6.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.75% |
| 2 | Technology | 15.19% |
| 3 | Consumer Discretionary | 13.45% |
| 4 | Industrials | 12.06% |
| 5 | Financials | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VSTO
926
DELISTED
Vista Outdoor Inc.
VSTO
| $338K | 0.03% |
42,192
+19,585
| +87% | +$192K |
|
927
La-Z-Boy
LZB
$1.69B
| $337K | 0.03% |
+10,219
| New | +$323K |
|
928
Badger Meter
BMI
$4.03B
| $336K | 0.03% |
+6,037
| New | +$336K |
|
929
Avis
CAR
$5.02B
| $336K | 0.03% |
9,645
-536
| -5% | -$16.1K |
|
930
Distribution Solutions Group
DSGR
$1.61B
| $336K | 0.03% |
21,402
-3,200
| -13% | -$48.3K |
|
931
QuinStreet
QNST
$1.21B
| $336K | 0.03% |
25,101
-29,585
| -54% | -$459K |
|
|
GCP
932
DELISTED
GCP Applied Technologies Inc.
GCP
| $336K | 0.03% |
+11,357
| New | +$305K |
|
|
BRKL
933
DELISTED
Brookline Bancorp
BRKL
| $335K | 0.03% |
23,295
+9,053
| +64% | +$136K |
|
|
RRD
934
DELISTED
RR Donnelley & Sons Co.
RRD
| $335K | 0.03% |
70,943
-199,090
| -74% | -$1.03M |
|
935
Ameris Bancorp
ABCB
$5.89B
| $334K | 0.03% |
9,716
+884
| +10% | +$32.9K |
|
936
Rollins
ROL
$18.2B
| $334K | 0.03% |
+12,030
| New | +$313K |
|
|
MNTV
937
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $334K | 0.03% |
+18,333
| New | +$258K |
|
938
PJT Partners
PJT
$4.38B
| $333K | 0.03% |
7,977
+1,864
| +30% | +$79.9K |
|
|
ZEPP
939
Zepp Health
ZEPP
$69.7M
| $332K | 0.03% |
6,350
+1,525
| +32% | +$82.3K |
|
|
CASA
940
DELISTED
Casa Systems, Inc. Common Stock
CASA
| $331K | 0.03% |
39,879
+20,589
| +107% | +$228K |
|
941
Calumet Specialty Products
CLMT
$3.44B
| $330K | 0.03% |
92,818
+56,130
| +153% | +$187K |
|
942
BioCryst Pharmaceuticals
BCRX
$2.4B
| $329K | 0.03% |
+40,383
| New | +$346K |
|
|
RDUS
943
DELISTED
Radius Recycling
RDUS
| $329K | 0.03% |
+13,706
| New | +$324K |
|
|
ACRE
944
Ares Commercial Real Estate
ACRE
$270M
| $327K | 0.03% |
+21,499
| New | +$313K |
|
|
PVLA
945
Palvella Therapeutics
PVLA
$2.27B
| $326K | 0.03% |
1,216
-268
| -18% | -$63.7K |
|
|
CADE
946
DELISTED
Cadence Bank
CADE
| $325K | 0.03% |
11,503
+1,218
| +12% | +$36.1K |
|
947
Weis Markets
WMK
$1.86B
| $324K | 0.03% |
7,930
-8,800
| -53% | -$414K |
|
948
Dollar Tree
DLTR
$25.2B
| $323K | 0.03% |
+3,076
| New | +$302K |
|
949
Reinsurance Group of America
RGA
$16.1B
| $323K | 0.03% |
+2,278
| New | +$328K |
|
|
EARN
950
Ellington Residential Mortgage REIT
EARN
$165M
| $321K | 0.03% |
26,951
+15,596
| +137% | +$180K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q1 2019 Portfolio in Review
As of Q1 2019, GSA Capital Partners held 1,870 positions worth $987M, up 14% from $867M the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.
GSA Capital Partners deployed $63.5M of net new capital in Q1 2019, opening 579 new positions and adding to 363 existing holdings. Its largest new stake was DexCom: 187,420 shares worth $5.58M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Lumen, an estimated $7.13M trimmed.
- GSA Capital Partners's largest Q1 2019 buy was DexCom: 187,420 shares worth $5.58M.
- GSA Capital Partners added most to Biogen in Q1 2019, an estimated $6.71M increase.
- GSA Capital Partners's biggest Q1 2019 reduction was Lumen, cutting an estimated $7.13M.
- GSA Capital Partners fully exited Canada Goose Holdings in Q1 2019, selling an estimated $21.9M.
- GSA Capital Partners's ten largest holdings make up 5.2% of its $987M portfolio in Q1 2019.
- GSA Capital Partners opened 579 new positions and closed 480 in Q1 2019.
- GSA Capital Partners's portfolio value rose 14% quarter-over-quarter to $987M.
Based on GSA Capital Partners's 13F filing for Q1 2019, filed 15 May 2019.